{
  "pmcid": "12492532",
  "sha256": "301745ada224f731b184286ba3a39e0a48d6daf2f6706e52b5e3feae91ba294e",
  "timestamp_utc": "2025-11-09T22:29:58.098247+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.08902255639098,
    "reading_ease": 27.728157894736853,
    "word_count": 228
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of CYP2C19 Metabolizer Phenotype and POAF Incidence after OPCABG"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 2,
        "evidence": "320 patients undergoing elective first-time OPCABG from May 2017 to November 2023"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients were categorized into normal metabolizer (NM), intermediate metabolizer (IM), and poor metabolizer (PM) groups based on CYP2C19 genotyping."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the incidence of POAF within the first week post-surgery."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "320 patients undergoing elective first-time OPCABG from May 2017 to November 2023"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "POAF incidence was 20.9% in the NM group, 35.7% in the IM group (HR 1.843, 95% CI 1.155 to 2.940; P = 0.0076), and 57.8% in the PM group (HR 3.363, 95% CI 1.753 to 6.499; P < 0.0001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding sources were not disclosed."
      }
    },
    "total_score": 13,
    "max_score": 25
  }
}